USA Financial Formulas’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.65M | Sell |
15,331
-2,606
| -15% | -$280K | 0.28% | 31 |
|
|
2025
Q1 | $1.81M | Buy |
17,937
+3,401
| +23% | +$343K | 0.3% | 20 |
|
|
2024
Q4 | $1.3M | Sell |
14,536
-2,118
| -13% | -$189K | 0.2% | 24 |
|
|
2024
Q3 | $1.4M | Sell |
16,654
-996
| -6% | -$83.5K | 0.22% | 34 |
|
|
2024
Q2 | $1.36M | Buy |
17,650
+13,710
| +348% | +$1.06M | 0.22% | 32 |
|
|
2024
Q1 | $270K | Buy |
3,940
+3,867
| +5,297% | +$265K | 0.04% | 158 |
|
|
2023
Q4 | $4.22K | Sell |
73
-21,849
| -100% | -$1.26M | ﹤0.01% | 265 |
|
|
2023
Q3 | $1.16M | Buy |
21,922
+1,751
| +9% | +$92.5K | 1.73% | 9 |
|
|
2023
Q2 | $1.09M | Sell |
20,171
-425
| -2% | -$23K | 1.68% | 11 |
|
|
2023
Q1 | $1.03M | Buy |
+20,596
| New | +$1.03M | 1.67% | 14 |
|
|
2022
Q3 | $5K | Buy |
129
+68
| +111% | +$2.64K | 0.01% | 123 |
|
|
2022
Q2 | $2K | Hold |
61
| – | – | ﹤0.01% | 190 |
|
|
2022
Q1 | $3K | Buy |
61
+37
| +154% | +$1.82K | ﹤0.01% | 200 |
|
|
2021
Q4 | $1K | Sell |
24
-22
| -48% | -$917 | ﹤0.01% | 302 |
|
|
2021
Q3 | $2K | Buy |
46
+22
| +92% | +$957 | ﹤0.01% | 307 |
|
|
2021
Q2 | $1K | Hold |
24
| – | – | ﹤0.01% | 338 |
|
|
2021
Q1 | $1K | Hold |
24
| – | – | ﹤0.01% | 290 |
|
|
2020
Q4 | $1K | Buy |
24
+5
| +26% | +$208 | ﹤0.01% | 256 |
|
|
2020
Q3 | $1K | Hold |
19
| – | – | ﹤0.01% | 243 |
|
|
2020
Q2 | $1K | Buy |
+19
| New | +$1K | ﹤0.01% | 149 |
|
|
2019
Q1 | – | Sell |
-91,676
| Closed | -$3.53M | – | 149 |
|
|
2018
Q4 | $3.53M | Buy |
+91,676
| New | +$3.53M | 0.88% | 36 |
|